The impact of an angiosome-targeted revascularization on healing rate, limb salvage and survival in critical limb threatening ischemia

References

• Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease. Int Angiol. 2007;26(2):81–157.
   PubMed Web of Science ®Google Scholar
• Taylor GI, Palmer JH. The vascular territories (angiosomes) of the body: experimental study and clinical applications. Br J Plast Surg. 1987;40(2):113–141.
   PubMedGoogle Scholar
• Dilaver N, Twine CP, Bosanquet DC. Editor’s choice - direct vs. indirect angiosomal revascularisation of infrapopliteal arteries, an updated systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2018;56(6):834–848.
   PubMed Web of Science ®Google Scholar
• Attinger CE, Evans KK, Bulan E, et al. Angiosomes of the foot and ankle and clinical implications for limb salvage: reconstruction, incisions, and revascularization. Plast Reconstr Surg. 2006;117(7):261S–293S.
   PubMed Web of Science ®Google Scholar
• Aerden D, Denecker N, Gallala S, et al. Wound morphology and topography in the diabetic foot: hurdles in implementing angiosome-guided revascularization. Int J Vasc Med. 2014;2014:672897.
   PubMedGoogle Scholar
• Sumpio BE, Forsythe RO, Ziegler KR, et al. Clinical implications of the angiosome model in peripheral vascular disease. J Vasc Surg. 2013;58(3):814–826.
   PubMed Web of Science ®Google Scholar
• Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg. 2019;58(1S):S1–S109.
   PubMed Web of Science ®Google Scholar
• Karmody AM, Leather RP, Shah DM, et al. Peroneal artery bypass: a reappraisal of its value in limb salvage. J Vasc Surg. 1984;1(6):809–816.
   PubMed Web of Science ®Google Scholar
• Spillerova K, Sorderstrom M, Alback A, et al. The feasibility of angiosome-targeted endovascular treatment in patients with critical limb ischemia and foot ulcer. Ann Vasc Surg. 2016;30:270–276.
   PubMed Web of Science ®Google Scholar
• Darling JD, McCallum JC, Soden PA, et al. Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia. J Vasc Surg. 2017;66(2):466–475.
   PubMed Web of Science ®Google Scholar
• Spillerova K, Biancari F, Leppaniemi A, et al. Differential impact of bypass surgery and angioplasty on angiosome-targeted infrapopliteal revascularization. Eur J Vasc Endovasc Surg. 2015;49(4):412–419.
   PubMed Web of Science ®Google Scholar
• Aboyans V, Ricco JB, Bartelink MEL, et al. Editor's choice - 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018;55(3):305–368.
   PubMed Web of Science ®Google Scholar
• Peregrin JH, Koznar B, Kovac J, et al. PTA of infrapopliteal arteries: long-term clinical follow-up and analysis of factors influencing clinical outcome. Cardiovasc Intervent Radiol. 2010;33(4):720–725.
   PubMed Web of Science ®Google Scholar
• Acin F, Varela C, Lopez de Maturana I, et al. Results of infrapopliteal endovascular procedures performed in diabetic patients with critical limb ischemia and tissue loss from the perspective of an angiosome-oriented revascularization strategy. Int J Vasc Med. 2014;2014:270539.
   PubMedGoogle Scholar
• Jeon EY, Cho YK, Yoon DY, et al. Clinical outcome of angiosome-oriented infrapopliteal percutaneous transluminal angioplasty for isolated infrapopliteal lesions in patients with critical limb ischemia. Diagn Interv Radiol. 2015;22(1):52–58.
   Web of Science ®Google Scholar
• Khan SZ, Dosluoglu HH. Should multiple vessels be recanalised for tissue loss irrespective of pedal anatomy and angiosome? Eur J Vasc Endovasc Surg. 2018;55(4):528.
   PubMed Web of Science ®Google Scholar
• Rashid H, Slim H, Zayed H, et al. The impact of arterial pedal arch quality and angiosome revascularization on foot tissue loss healing and infrapopliteal bypass outcome. J Vasc Surg. 2013;57(5):1219–1226.
   PubMed Web of Science ®Google Scholar
• Troisi N, Turini F, Chisci E, et al. Pedal arch patency and not direct-angiosome revascularization predicts outcomes of endovascular interventions in diabetic patients with critical limb ischemia. Int Angiol. 2017;36(5):438–444.
   PubMed Web of Science ®Google Scholar
• Zheng XT, Zeng RC, Huang JY, et al. The use of the angiosome concept for treating infrapopliteal critical limb ischemia through interventional therapy and determining the clinical significance of collateral vessels. Ann Vasc Surg. 2016;32:41–49.
   PubMed Web of Science ®Google Scholar
• Varela C, Acin F, de Haro J, et al. The role of foot collateral vessels on ulcer healing and limb salvage after successful endovascular and surgical distal procedures according to an angiosome model. Vasc Endovascular Surg. 2010;44(8):654–660.
   PubMed Web of Science ®Google Scholar
• Popplewell MA, Davies H, Jarrett H, et al. Bypass versus angio plasty in severe ischaemia of the leg - 2 (BASIL-2) trial: study protocol for a randomised controlled trial. Trials. 2016;17:11.
   PubMedGoogle Scholar
• Farber A, Rosenfield K, Menard M. The BEST-CLI trial: a multidisciplinary effort to assess which therapy is best for patients with critical limb ischemia. Tech Vasc Interv Radiol. 2014;17(3):221–224.
   PubMedGoogle Scholar
• Bradbury AW. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial in perspective. J Vasc Surg. 2010;51(5):1S–4S.
   PubMedGoogle Scholar